What Logipren does

Logipren, legally SAS LogipremF, is a French medical device software company headquartered in Saint-Pierre, La Réunion, with a commercial office in Paris. The company develops a CE-marked Class IIB computerized prescription order entry and clinical decision support system purpose-built by neonatologists for neonatal and pediatric intensive care units. The platform is anchored by a proprietary Reference Thesaurus covering 700 medications validated by the French Society of Neonatology, which suggests drug protocols based on gestational age, postnatal age, corrected age, weight, and clinical indications while eliminating manual calculations and integrating parenteral and enteral nutrition prescription. The software is deployed as a pure web thin-client on hospital intranets and integrates with hospital information systems via HL7 ADT, IHE PAM, HL7 Pharmacy, and a proprietary REST API, alongside connectors to pharmacy/nutrition robots such as BAXA EM2400, BP'Prep, and MoLactarium.

Logipren sells primarily through an enterprise field sales motion targeting hospital procurement and clinical leadership, with a 4-step implementation process including parametrization by medical and pharmacy referents. Revenue is generated through subscription-based licensing of the software as a regulated medical device, with associated implementation, training, and ongoing support services, complemented by EU and La Réunion regional co-funding for R&D activities. The company serves 60+ healthcare institutions across metropolitan France and overseas territories, with 150,000+ patients treated and 360+ physicians and pharmacists active in the Logipren Community.

The platform is reinforced by the B-PEN Health Data Warehouse, a pseudonymized prescription data repository from 30+ NICUs governed by a Scientific and Ethics Committee including the SFN, SFPC, CEPOI, and INSERM, which produces annual inter-institution benchmarking reports and supports peer-reviewed clinical research. Core technology integration partnerships include Vidal France for drug database cross-validation, Bow Médical DIANE for ICU continuity, Evolucare Save for critical care, and B.Braun for infusion workflows. The company is co-funded by the European Union, the La Réunion Region, and Bpifrance.

Name

Logipren

Legal name

SAS LogipremF

Website

https://logipren.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Logipren (SAS LogipremF) provides CE-marked Class IIB prescription decision-support software for hospital neonatal and pediatric intensive care units in France. The platform combines a proprietary 700-drug Reference Thesaurus with B-PEN benchmarking data, deployed across 60+ institutions.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

SIC

Services-Health Services (8000)

akta.pro primary industry

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)

akta.pro secondary industry

Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

Keywords

• Neonatal prescription software
• Clinical decision support
• Pediatric intensive care software
• Medical device software
• Drug reference thesaurus

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Software as Medical Device License (Subscription): Logipren is sold and deployed as a CE-marked Class IIB medical device software license to hospital neonatal and pediatric intensive care units. Revenue is generated through software licensing with associated implementation, parametrization, training, and ongoing support services. The company also benefits from EU and La Réunion regional co-funding for research and development activities.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Logipren is a CE-marked Class IIB medical device software that assists with drug and parenteral nutrition prescriptions in neonatal and pediatric intensive care units. It combines a proprietary Reference Thesaurus of 700 medication protocols validated by the French Society of Neonatology with a 3-click prescription engine that automates dosing calculations and integrates drug and nutrition prescription. The platform is deployed as a pure web thin-client on hospital intranets and connects with hospital information systems via HL7, IHE, and a proprietary REST API.

Product overview

Logipren is a unified medical software platform designed by neonatologists for neonatal and pediatric intensive care prescription management. The core offering consists of the Logipren Software (prescription order entry and clinical decision support system with CE Class IIB marking), supported by a proprietary Reference Thesaurus database of 700 medications, the B-PEN Health Data Warehouse for benchmarking and clinical research, and the Logipren Community for professional exchange. The platform provides end-to-end protection from prescription through administration, including drug preparation, enteral and parenteral nutrition management, with integration to hospital systems via HL7 standards and a proprietary REST API.

Differentiator

Problem solved

Functional benefit

Products and services

• Logipren Software CE-marked Class IIB computerized prescription order entry and clinical decision support system designed by neonatologists for neonatal and pediatric intensive care units. Provides drug prescription, parenteral nutrition, and care plan management with a proprietary Reference Thesaurus of 700 medications and 3-click protocol-based prescription that eliminates manual calculations. Deployed as a pure web thin-client on hospital intranets with HL7/IHE integration.
• B-PEN Health Data Warehouse Centralized prescription database and research platform that aggregates pseudonymized prescription data from 30+ French NICUs participating in the B-PEN (Benchmarking in Neonatology Prescription) program. Enables annual benchmarking reports comparing prescription practices across neonatal units and supports clinical research on drugs and nutrition in neonatology under oversight of a Scientific and Ethics Committee (SFN, SFPC, CEPOI, INSERM).
• Logipren Community Online professional community platform for physicians and pharmacists to exchange on neonatal prescription issues and Reference Thesaurus configuration in real time. Accessible directly from the Logipren software or via smartphone through the Talkspirit application. Includes 360+ members of healthcare professionals who participate in discussions and knowledge sharing.
• Logipren Reference Thesaurus Proprietary regularly updated drug database containing prescription protocols for 700 medications most used in neonatology and pediatric intensive care. Rules validated by the Société Française de Néonatologie and combining AMM recommendations, national guidelines (SFN, ANSM, HAS), American Pharmacist Association references, and peer-reviewed international literature. Powers the prescription decision support across all equipped institutions.

Quantifiable outcome

• Drug-related errors occur in 1 out of 6 manual prescriptions in neonatology (Horri J et al. J Clin Pharm Ther 2014; Campino et al. An Pediatr 2006). Logipren's electronic prescribing eliminates manual calculations and transcription, reducing this error rate.
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Vidal (Vidal France)coreTechnology or IntegrationVidal provides the certified drug database (Vidal Médicaments) to which Logipren cross-validates prescriptions, ensuring drug safety and compliance with French HAS certification requirements. Vidal integrates prescription decision-support data into over 200 software products in France and internationally.
• CHU de La RéunioncoreStrategic or Co-development PartnerThe University Hospital of La Réunion is the origin institution of the B-PEN (Benchmarking in Neonatology Prescription) research project that led to Logipren's creation. The hospital hosts the Health Data Warehouse and provides ongoing clinical research collaboration through the Scientific and Ethics Committee (with SFN, SFPC, CEPOI, INSERM).
• CHU de La Réunion / B-PEN Study GroupcoreStrategic or Co-development PartnerThe B-PEN (Benchmarking in Neonatology Prescription) program involves 30+ French NICUs contributing pseudonymized prescription data to the Health Data Warehouse. Managed by a Scientific and Ethics Committee including SFN, SFPC, CEPOI, and INSERM representatives. Annual benchmarking reports generated and reviewed at joint hospital meetings.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Elsevier Clinical Solutions: Elsevier's ClinicalPath, Order Sets, and clinical decision support solutions serve hospitals globally with evidence-based content. As a broad incumbent in evidence-based CDS, Elsevier represents both a content partner opportunity and a competitive threat in clinical decision support for prescribing.
• Epic Systems: Epic's enterprise EHR includes CPOE and clinical decision support with growing pediatric/neonatal content. While not focused exclusively on neonatology, large Epic installations in European academic hospitals represent a potential long-term competitive threat to point solutions like Logipren.
• Oracle Health (formerly Cerner): Oracle Health's EHR and Millennium platform include CPOE and CDS capabilities used in academic hospitals. As a global broad incumbent, it could expand neonatal-specific functionality and compete with Logipren in larger French/European academic medical centers.
• CompuGroup Medical: CompuGroup Medical is a major European health IT vendor with hospital information systems and CPOE offerings. As a broad incumbent, it competes for the same French and European hospital IT budgets and could expand specialty pediatric offerings to challenge Logipren's niche.
• Maincare Solutions: Maincare is a major French hospital IT vendor with EHR and clinical information system offerings. As a broad incumbent, it represents an enterprise-wide alternative that could subsume Logipren's specialty NICU use case within a larger hospital IT contract.
• Dedalus: Dedalus is a leading European hospital information systems vendor with broad CPOE/EHR offerings across multiple specialties. As a broad incumbent, it competes with Logipren at the hospital-wide IT level and could threaten Logipren by adding deeper neonatal modules to its existing footprint.

Others

• Vidal (Wolters Kluwer): Vidal is the French certified drug database provider whose data Logipren uses for prescription cross-validation. Vidal is also an enabling technology partner that distributes prescription decision-support data into 200+ software products — making it both a critical dependency and a potential competitor should it vertically integrate into prescription SaaS.
• B.Braun: B.Braun is a multi-specialist medical device company whose Spaceplus infusion devices and parenteral nutrition systems integrate with hospital IT. While not a direct software competitor, B.Braun is an adjacent technology/infrastructure partner whose compounding devices connect to neonatal workflows where Logipren operates.

Direct peers

• Bow Médical: Bow Médical's DIANE suite (including DIANE RÉA for ICU prescription) is directly interoperable with Logipren and serves a comparable French hospital critical-care IT market. Both target anesthesia/ICU departments with CPOE functionality, making Bow the closest direct competitor for prescription-management mindshare in French hospitals.
• Evolucare Technologies: Evolucare's Soins Critiques (Save) suite covers surgical, anesthesia, and ICU operations in French hospitals. It competes for the same critical-care IT budget pool as Logipren, with potential overlap on integrated patient care management across ICU and neonatal environments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Logipren-1941914792594634
• LinkedInlinkedin.com/company/logipren/?viewAsMember=true

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Logipren